OverviewChartTechnicalNewsTraderScreen

Evoke Pharma Inc/  US30049G2030  /

NASDAQ
2024-05-08  9:43:20 PM Chg. 0.0000 Volume Bid1:50:01 AM Ask1:50:01 AM High Low
0.4700USD 0.00% 31,709
Turnover: 8,753.9334		 0.4150Bid Size: 100 0.7500Ask Size: 2,000 0.4800 0.4610
GlobeNewswire 04-17 Evoke Pharma to Host Virtual Key Opinion Leader (KOL) Webinar on the Evolving Landscape of Gastropar...
GlobeNewswire 03-21 Evoke Pharma Announces Senior Leadership Transition with Promotion of Matthew J. D’Onofrio to Chief ...
GlobeNewswire 03-14 Evoke Pharma Reports Fourth Quarter and Full Year 2023 Financial Results
GlobeNewswire 03-07 Evoke Pharma to Report Fourth Quarter and Full Year 2023 Results on March 14, 2024
GlobeNewswire 02-14 Evoke Pharma Announces Closing of $7.5 Million Public Offering
GlobeNewswire 02-09 Evoke Pharma Announces Pricing of Underwritten Public Offering of up to $30 Million
GlobeNewswire 2023-11-27 Evoke Pharma Announces FDA Orange Book Listing of New GIMOTI Patent
GlobeNewswire 2023-11-14 United States Patent and Trademark Office (USPTO) Grants Another Formulation Patent Covering GIMOTI
GlobeNewswire 2023-11-09 Evoke Pharma Reports Third Quarter 2023 Financial Results
GlobeNewswire 2023-10-31 Evoke Pharma & EVERSANA Unveil Cost Savings Real-World Data Demonstrating Meaningfully Reduced Healt...
GlobeNewswire 2023-10-18 Evoke Pharma’s Abstract Entitled “Superiority of Nasal Spray Compared to Orally Administered Metoclo...
GlobeNewswire 2022-03-10 Evoke Pharma Announces Key Opinion Leader Fireside Chat to Discuss Gastroparesis Treatment Landscape
GlobeNewswire 2022-03-08 Evoke Pharma Reports Fourth Quarter and Full Year 2021 Financial Results
GlobeNewswire 2022-03-01 Evoke Pharma to Report Fourth Quarter and Full Year 2021 Financial Results on March 8, 2022
GlobeNewswire 2022-02-17 GIMOTI® Commercialization Update
GlobeNewswire 2022-02-02 Evoke Pharma and EVERSANA Extend Commercialization Partnership to Further Support GIMOTI
GlobeNewswire 2022-01-04 Evoke Pharma to Participate in the H.C. Wainwright BIOCONNECT Virtual Conference
GlobeNewswire 2021-11-10 Evoke Pharma Reports Third Quarter 2021 Financial Results
GlobeNewswire 2021-11-03 Evoke Pharma to Report Third Quarter 2021 Financial Results on November 10, 2021
GlobeNewswire 2021-10-20 Evoke Pharma and EVERSANA Announce Positive Findings from GIMOTI® Market Research Study
GlobeNewswire 2021-09-29 Evoke Pharma’s Commercial Partner EVERSANA, Receives PM360’s Trailblazer Initiative Award for Innova...
GlobeNewswire 2021-09-01 Evoke Pharma to Participate in the H.C. Wainwright 23rd Annual Global Investment Conference
GlobeNewswire 2021-08-12 Evoke Pharma Reports Second Quarter 2021 Financial Results
GlobeNewswire 2021-08-05 Evoke Pharma to Report Second Quarter 2021 Financial Results on August 12, 2021
GlobeNewswire 2021-08-02 Evoke Pharma and EVERSANA Announce Support of The International Foundation for Gastrointestinal Diso...